BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions
Primary Hyperoxaluria Type 1
Trial Locations (30)

15213

RECRUITING

Clinical Trial Site, Pittsburgh

20010

COMPLETED

Clinical Trial Site, Washington D.C.

45229

RECRUITING

Clinical Trial Site, Cincinnati

55905

RECRUITING

Clinical Trial Site, Rochester

75390

RECRUITING

Clinical Trial Site, Dallas

77030

RECRUITING

Clinical Trial Site, Houston

85016

RECRUITING

Clinical Trial Site, Phoenix

02115

RECRUITING

Clinical Trial Site, Boston

Unknown

RECRUITING

Clinical Trial Site, Ghent

RECRUITING

Clinical Trial Site, Liège

RECRUITING

Clinical Trial Site, Hamilton

RECRUITING

Clinical Trial Site, Toronto

RECRUITING

Clinical Trial Site, Laurier

RECRUITING

Clinical Trial Site, Bordeaux

RECRUITING

Clinical Trial Site, Lyon

RECRUITING

Clinical Trial Site, Paris

RECRUITING

Clinical Trial Site, Berlin

RECRUITING

Clinical Trial Site, Cologne

RECRUITING

Clinical Trial Site, Hamburg

RECRUITING

Clinical Trial Site, Jerusalem

RECRUITING

Clinical Trial Site, Orbassano

RECRUITING

Clinical Trial Site, Milan

RECRUITING

Clinical Trial Site, Verona

RECRUITING

Clinical Trial Site, Amsterdam

RECRUITING

Clinical Trial Site, Santa Cruz de Tenerife

RECRUITING

Clinical Trial Site, Barcelona

RECRUITING

Clinical Trial Site, Las Palmas

RECRUITING

Clinical Trial Site, Bern

RECRUITING

Clinical Trial Site, London

RECRUITING

Clinical Trial Site, London

Sponsors
All Listed Sponsors
lead

Alnylam Pharmaceuticals

INDUSTRY